leading to the development of such symptoms as acute rhinitis, bronchospasm, cramping, diarrhea or cutaneous wheal and flare responses. In addition to these effects on the immediate type response histamine significantly regulates the immune response and a number of chronic phase inflammatory events (1, 2) . For example, histamine is increased in bronchoalveolar lavage fluid from patients with allergic asthma and this increase negatively correlates with airway function (7) . An increase in histamine levels has been noted in the skin and plasma of patients with atopic dermatitis (8) and in chronic urticaria (9) . Histamine levels are also increased in multiple sclerosis (10) and in psoriatic skin (11) . Both plasma and synovial fluid of patients with rheumatoid arthritis and plasma of patients with psoriatic arthritis have increased histamine levels (12) . Consequently the antihistamines should be viewed as systemic anti-allergic agents and immunoregulators.
Histamine receptors
The pleiotropic effects of histamine are triggered by activating on one or several of histamine membrane receptors on different cells. Four subtypes of receptors (histamine receptor (HR) 1, HR2, HR3, and HR4) have been described (Table 1 ). All of these receptors belong to the G-protein-coupled receptor family. They are heptahelical transmembrane molecules that transduce extracellular signal by using G-proteins and intracellular second messenger systems (1, 2) . The active and inactive states of HRs exist in equilibrium. However, it has been shown in recombinant systems that HRs can trigger downstream events in the absence of receptor occupancy by an agonist, which accounts for constitutive spontaneous receptor activity (13) .
HRs agonists stimulate the active state in the receptor and inverse agonists, the inactive one. An agonist with a preferential affinity for the active state of the receptor stabilizes the receptor in its active conformation leading to continuous activation signal. An inverse agonist with a preferential affinity for the inactive state stabilizes the receptor in this conformation and consequently induces an inactive state, which is characterized by blocked signal transduction via the HR (13) . In reporter gene assays, constitutive HR1-mediated nuclear factor (NF)-κB activation has been shown to be inhibited by many of the clinically used H1-antihistamines, indicating that these agents are inverse HR1-agonists (13) . Constitutive activity has now been shown for all four histamine receptors (13) .
Specific activation or blockade of HRs showed that they differ in expression, signal transduction or function and improved the understanding of the role of histamine in physiology and disease mechanisms. It has long been recognized that most positive effects of histamine are mediated by HR1, while HR2 is mostly involved in its suppressive activities. The human G q/11 -coupled HR1 is encoded by a single exon gene located on the distal short arm of chromosome 3p25b and contains 487 aminoacids. The HR1 is expressed in numerous cells including airway and vascular smooth muscle cells, hepatocytes, chondrocytes, nerve cells, endothelial cells, dendritic cells, monocytes, neutrophils, T and B cells (1, 2) . Histamine binds to transmambrane domains 3 and 5. Activation of the HR1-coupled G q/11 stimulates the inositol phospholipid signaling pathways resulting in formation of inositol-1,4,5-triphosphate (IP 3 ) and diacylglycerol and an increase in intracellular calcium (14) .
The rise in intracellular calcium accounts for nitric oxide production, liberation of arachidonic acid from phospholipids increased cyclic AMP. The HR1 also activates phospholipase D and phospholipase A 2 and the transcription factor NF-κB. through G q/11 and G βγ upon agonist binding. Constitutive activation of NF-κB occurs only through G βγ (14) . The HR1 is responsible for the development of many symptoms of allergic disease. Targeted disruption of the H1-receptor gene in mice results in the impairment of neurologic functions such as memory, learning, locomotion, and nocioperception, and in aggressive behavior. Immunologic abnormalities have also been described in HR1-deleted mice, with impairment of both T and B cell responses (15) . Activation of HR1 is responsible for many symptoms of allergic disease.
In humans the intronless gene encoding HR2 is located on chromosome 5. The human HR2 is a protein of 359 aminoacids coupled to both adenylate cyclase and agonists. Probably more than one HR3 subtype exists, which differ in central nervous system localization and signaling pathways.
Human HR4, which is encoded by a gene containing three exons, separated by two large introns located in chromosome 18q11.2. It has 37-43% homology to HR3
(58% in the transmembrane region). HR4 is functionally coupled to G protein G i/o , inhibiting forskolin-induced cAMP formation like the HR3 [14] . HR4 shows high expression in the bone marrow and peripheral hematopoietic cells, neutrophils, eosinophils and T cells, basophils and mast cells and moderate expression in spleen, thymus, lung, small intestine, colon, and heart (18) . Until now relatively little is known about the biological function of HR4. It seems to be involved in the immune regulatory functions including chemotaxis and cytokine secretion (1, 2) . H4 histamine receptor is expressed in cells of the innate immune system, which include NK cells, monocytes, and dendritic cells (19) .
HRs form dimers and even oligomers, which allow cooperation between HRs and other G protein-coupled receptors. Thus, the effects of histamine upon receptor stimulation can be very complex.
Synthesis and metabolism of histamine
The classical cellular sources of histamine are mast cells and basophils, gastric enterochromaffin-like cells, platelets and histaminergic neurons. Interestingly the cells in the immune system, which do not store histamine show high HDC activity and are capable of production of high amounts of histamine, which is secreted immediately after synthesis (20) . These cells include platelets, monocytes/macrophages, dendritic cells, neutrophils, T and B lymphocytes.
Histamine is synthesized by decarboxylation of histidine by L-histidine decarboxylase (HDC), which is dependent on the cofactor pyridoxal-5´-phosphate HDC activity has been demonstrated in vivo in conditions such as LPS stimulation, infection, inflammation, and graft rejection (14) . The generation of HDC-deficient mice provided histamine-free systems to study the role of endogenous histamine in a broad range of normal and disease processes. These mice show decreased numbers of mast cells and significantly reduced granule content, which suggests that histamine might affect the synthesis of mast cell granule proteins (23) . IgE binding to the FcεRI on IL-3-dependent mouse bone marrow-derived mast cells induces the expression of HDC through a signaling pathway distinct to that operating during antigen-stimulated FcεRI activation (24) . More than 97% of the histamine is metabolized in 2 major pathways before excretion (25) . Histamine Nmethyltransferase metabolizes the majority of histamine to N-methylhistamine, which is further metabolized to the primary urinary metabolite M-methylimidazole acetic acid by monoamine oxidase. Diamine oxidase metabolizes 15% to 30% of histamine to imidazole acetic acid.
Histamine in chronic inflammatory responses
Chronic inflammatory response is one of the hallmarks of allergic diseases.
Over the course of pollen season, there might be even a 10-fold increase in numbers of nasal epithelial submucosal mast cells. Histamine released from these cells might not only induce acute allergic symptoms but also be crucial for sustaining this response into a chronic phase as increasing evidence suggests that it influences several immune/inflammatory and effector functions ( Table 2) 
Effect of histamine on T cells and antibody isotypes
Histamine has been shown to intervene in the Th1, Th2, Treg cell balance and Peripheral T cell tolerance characterized by immune deviation to regulatory/suppressor T cells represents a key event in the control of specific immune response during allergen-specific immunotherapy (85) . Although, multiple suppressor factors including contact dependent or independent mechanisms might be involved, IL-10 and TGF-β predominantly produced by allergen-specific T cells play an essential role (86, 87) . Histamine interferes with the peripheral tolerance induced during SIT in several pathways. Histamine induces the production of IL-10 by dendritic cells (88) . In addition, histamine induces IL-10 production by Th2 cells (89) .
Furthermore, histamine enhances the suppressive activity of TGF-β on T cells (90) .
All three of these effects are mediated via HR2, which is relatively highly expressed on Th2 cells and suppresses IL-4 and IL-13 production and T cell proliferation .
Apparently, these recent findings suggest that HR2 may represent an essential receptor that participates in peripheral tolerance or active suppression of inflammatory/immune responses. Although the selective activation of H2R might be a more promising approach as compared to the use of H1 antihistamines, so far it has not been investigated in vivo.
However, selective HR2 antagonists, have attracted interest because of their potential immune response-modifying activity (91) . Most data suggest that cimetidine has a stimulatory effect on the immune system, possibly by blocking the receptors on subsets of T-lymphocytes and inhibiting HR2-induced immune suppression.
Cimetidine has also been used successfully to restore immune functions in patients with malignant disorders, hypogammaglobulinemia and AIDS-related complexes. antihistamine treatment (3, (92) (93) (94) (95) . Treatment with the H 1 -antihistamine cetirizine over a period of 18 months was reported to delay the onset of asthma in some young children with atopic dermatitis who were at high risk for the disease, however, this observation requires confirmation (3, (92) (93) (94) (95) . In sensitized mice, treatment with the H 1 -antihistamine fexofenadine before allergen challenge prevented airway hyperresponsiveness. Decreases in bronchoalveolar lavage fluid and tissue eosinophilia, lymphocyte numbers, and T H 2 cytokine production were also observed in this model (96) . Another HR1 antihistamine, desloratadine, given at the time of allergen exposure, inhibited the induction of allergic inflammation in the airways and bronchial hyperresponsiveness (97) .
The use of H1 antihistamines in asthma
Histamine-induced, concentration-dependent release of IL-6 and β-glucuronidase from macrophages isolated from human lung parenchyma can be consistently inhibited by fexofenadine but not by ranitidine, an H 2 -antihistamine (98).
Thus, long-term treatment with HR1 antihistamines might potentially alter disease progression in patients with respiratory allergy associated with tissue damage/remodeling mediated by macrophage and Th2 cell activation.
Although previous studies suggested a basal tone of smooth muscle mediated by histamine binding to HR1, constitutive intrinsic activity of the HR1 without any occupation by histamine might be more relevant. Histamine also induces proliferation of cultured airway smooth muscle cells (66) .
Species differences in the response to histamine have been reported. HR2-mediated bronchodilation occurs in cats, rats, rabbits, sheep and horses (67);
however, in healthy and asthmatic humans, H 2 -antihistamines such as cimetidine and ranitidine do not cause bronchoconstriction (99, 100) . Although there is no direct evidence that it plays a role in disease pathogenesis, HR2-mediated gastric secretion may be impaired in asthma (101) . H 2 -antihistamines, given for the treatment of gastroesophageal reflux, improve asthma symptoms (102) ; whether this is an indirect effect due to down-regulation of gastric acid secretion, or whether it is a direct effect remains to be elucidated. In addition, recent studies suggest that histamine may play an important role in the modulation of the cytokine network in the lung via HR2, HR3
and HR4 that are expressed in distinct cells and cell subsets (103, 104) . Apparently, due to the same signal transduction patterns, β2 adrenergic receptors may function similar to HR2 in humans (105) . Future research should focus on the role of histamine and other redundant G-protein-coupled receptors in the regulation of immune/inflammatory pathways in the lung.
In particular, the discovery of a fourth histamine receptor (H4) and its expression on numerous immune and inflammatory cells has prompted a reevaluation of the actions of histamine, suggesting a new potential for H4-receptor antagonists and a possible synergy between H1 and H4-receptor antagonists in targeting various inflammatory conditions (106) .
Conclusions
The 
